Lacidipine: Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
No edit summary |
||
| Line 41: | Line 41: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category: Calcium channel blockers]][[Category: Selective calcium channel blockers with mainly vascular effects]][[Category: Dihydropyridine derivatives]][[Category: Cardiovascular Drugs]] | |||
[[Category: Drug]] | |||
Revision as of 14:35, 23 July 2014
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C26H33NO6 |
| Molar mass | 455.543 g/mol |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Lacidipine (tradenames Lacipil, Motens) is a calcium channel blocker. It is available as tablets containing 2 or 4 mg.
External links
- Motens 2 mg Summary of Product Characteristics
- Motens 4 mg Summary of Product Characteristics
Categories:
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Carboxylate esters
- Drugs
- Calcium channel blockers
- Selective calcium channel blockers with mainly vascular effects
- Dihydropyridine derivatives
- Cardiovascular Drugs
- Drug